Sherly Mardiana, PhD

Principal Scientist, Research/Discovery at Carisma Therapeutics

Speaker

Sherly Mardiana serves as a Principal Scientist in the Research/ Discovery Group at Carisma Therapeutics, where she focuses on developing novel approaches for macrophage-based therapies in solid cancer. Sherly obtained her PhD from the University of Melbourne, Australia, with a focus on developing novel combination approaches to enhance CAR T cell efficacy in solid tumors. After completion of her PhD, Sherly spent 3 years as a postdoctoral trainee at the University of Pennsylvania under the supervision of Dr. Saar Gill. Overall, Sherly has over 10 years of experience in developing adoptive cell therapy, specializing in chimeric antigen receptor (CAR)-based T cell and macrophage therapies.